Health In Tech, Inc.
About Health In Tech, Inc.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $33.3M
- Net income
- $1.3M
- Total assets
- $23.1M
- Market cap
- $64.7M
- Gross margin
- 62.8%
- Operating margin
- 41.8%
- Net margin
- 3.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $33.3M
- Cost of revenue
- $12.4M
- Gross profit
- $20.9M
- Operating expenses
- $19.4M
- Operating income
- $13.9M
- Income tax
- $395.3K
- Net income
- $1.3M
- EPS (basic)
- $0.02
- EPS (diluted)
- $0.02
Balance sheet
- Total assets
- $23.1M
- Current assets
- $16.2M
- Total liabilities
- $6.0M
- Current liabilities
- $5.2M
- Shareholders’ equity
- $17.1M
Cash flow
- Operating cash flow
- $3.1M
- Investing cash flow
- -$3.1M
- Financing cash flow
- -$187.4K
- Net cash flow
- -$179.5K
Statements via Polygon.io (SEC filings)
- Market cap
- $64.7M
- P/E ratio
- 50.0
- EPS (diluted)
- $0.02
- Dividend yield
- 76.7%
- Shares outstanding
- 64.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 23, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $1.3M in FY2025.
- Revenue grew 71% from FY2024 to FY2025.
- Gross margin of 62.8%, net margin 3.8%.
- Trading 73% below its 52-week high.
- Pays a dividend yielding about 76.7% annually.
- Valued at a price-to-earnings (P/E) ratio of 50.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Health In Tech, Inc..
